EUVIMEDEUVIMED entdecken
Open Access

Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements

Haya S Raef, Lina Rebeiz, Rebecca Karp Leaf, Olivia Hughes, Paul Jiang, Abrahim ElSeht, Karl E Anderson, Kristen Wheeden, Irene Kochevar, Sarina B Elmariah, Amy K Dickey

JAMA Dermatology · 01.02.2023 · 159 (2) · 204

DOI: 10.1001/jamadermatol.2022.5850 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.02.2023. Verfasst von Haya S Raef und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Massachusetts General Hospital, Boston. Hauptthemen laut MEDLINE: Protoporphyria, Erythropoietic. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Erythropoietic protoporphyria (EPP) is a rare and underdiagnosed genetic disease characterized by painful sensitivity to light. A better understanding and characterization of its light-induced cutaneous symptoms may aid in the identification of EPP in patients.

Objectives

To describe the cutaneous symptoms of erythropoietic protoporphyria (EPP) and to determine if these symptoms are associated with the degree of light sensitivity. Design, Setting, and Participants This was a cross-sectional study of adolescent and adult (≥15 years) patients with EPP across the US conducted by a single academic hospital via a remotely administered survey, measurements of light sensitivity by light dosimetry and by text message symptom assessments. Data analyses were conducted from November 2020 to April 2022. Exposures Sunlight exposure. Main Outcomes and Measures Self-reported symptoms and association with measured light sensitivity.

Results

The study sample consisted of 35 patients with EPP (mean [SD] age, 39.1 (15.5) years; 21 [60%] female; 14 [40%] male; 35 [100%] White individuals). The patients’ median [range] skin tone was 3.0 (1.0-8.0), based on self-reporting from 1 (lightest) to 12 (darkest). A total of 24 participants completed the light dosimeter measurements. Phototoxic reactions were characterized by pain (97%; 34 patients), burning (97%; 34), tingling (97%; 34), pruritus (83%; 29), allodynia (89%; 31), improvement of symptoms with cold (89%; 31), achiness (24%; 12), fatigue (46%; 16), mild swelling (83%; 29), severe swelling (63%; 22), erythema (51%; 18), petechiae (40%; 14), skin cracking (43%; 15), scabbing (46%; 16), scarring (66%; 23), and other chronic skin changes (40%; 14). Patients with EPP reported that their hands, feet, and face were most sensitive to light and that their shoulders and legs were least sensitive; 25.7% (9 patient) reported no chronic skin changes, and 5.7% (2 patients) reported never having had any visible symptoms. None of these findings varied with the degree of light sensitivity except that lower overall light sensitivity was associated with lower ranked sensitivity of the neck and arms. Conclusions and Relevance The findings of this cross-sectional study suggest that patients with EPP have distinctive cutaneous symptoms that may aid in identification of this underdiagnosed disease. Characteristic EPP symptoms include light-induced cutaneous burning pain and occasional swelling, particularly over the hands, with a prodrome of pruritus and paresthesias. Minimal skin changes or the absence of visible skin changes during reactions to light, including lack of erythema, do not exclude an EPP diagnosis nor suggest low EPP disease burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protoporphyria, ErythropoieticAdultAdolescentHumansMaleFemalePhotophobiaCross-Sectional StudiesErythemaPruritusParesthesia

Autor:innen und Institutionen

  • Department of Medicine, Massachusetts General Hospital, Boston.
  • Department of Dermatology, Massachusetts General Hospital, Boston.
  • Harvard Medical School, Boston, Massachusetts.
  • Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts.
  • Department of Internal Medicine, Division of Gastroenterology and Hepatology, University of Texas Medical Branch, Galveston.
  • United Porphyrias Association, Bethesda, Maryland.

Förderung

  • NIAMS NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Raef, H. S., Rebeiz, L., Leaf, R. K., Hughes, O., Jiang, P., ElSeht, A., Anderson, K. E., Wheeden, K., Kochevar, I., Elmariah, S. B., & Dickey, A. K. (2023). Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements. JAMA Dermatology, 159(2), 204. https://doi.org/10.1001/jamadermatol.2022.5850

Vancouver

Raef HS, Rebeiz L, Leaf RK, Hughes O, Jiang P, ElSeht A, et al. Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements. JAMA Dermatology. 2023;159(2):204. doi:10.1001/jamadermatol.2022.5850

BibTeX
@article{Raef2023,
  author = {Raef, Haya S and Rebeiz, Lina and Leaf, Rebecca Karp and Hughes, Olivia and Jiang, Paul and ElSeht, Abrahim and Anderson, Karl E and Wheeden, Kristen and Kochevar, Irene and Elmariah, Sarina B and Dickey, Amy K},
  title = {Light-Related Cutaneous Symptoms of Erythropoietic Protoporphyria and Associations With Light Sensitivity Measurements},
  journal = {JAMA Dermatology},
  year = {2023},
  volume = {159},
  number = {2},
  pages = {204},
  doi = {10.1001/jamadermatol.2022.5850}
}
Kostenlos starten →